United States: A study looked at how much salt people eat and how it relates to lung diseases, like interstitial lung disease (ILD) and pulmonary sarcoidosis. Researchers used data from a big health study done in 2019 to understand these relationships better.
They used special methods to analyze the data and find patterns. Over the last 30 years, people around the world have been eating less salt.
Two LASSO and generalized additive models both indicated dietary sodium intake is presumably of-course associated with the incidence and prevalence of ILD and pulmonary sarcoidosis.
In the overall exposure‒response curve, a dose‒effect relationship between dietary sodium and the incidence, prevalence of ILD and pulmonary sarcoidosis was seen.
As reported by nature.com, the maximum lag-specific RR of extremely high dietary sodium intake was 1.75 (95% CI: Altogether, SCD incidence was significantly higher than the reference at 61–1.91 (95% CI: 1.07–2.95, lag 0 year) for incidence and 3.19 (95% CI: 2.24–4.53, lag 0 year) for prevalence.
Based on our study, we recommend that dietary sodium intake significantly influences the incidence and progression of ILD and pulmonary sarcoidosis. These findings may be honestly imperative for policymaking related to dietary sodium intake-reduction and the interventions which are targeting a reduction in the burden of respiratory disorders and supporting overall population health.
Interstitial lung complaint is basically inflammation or fibrosis within the pulmonary interstitium; there are about 200 different conditions with analogous clinical, radiographic, physiological, and pathological instantiations ILD. ILD may be divided into the following groups Idiopathic interstitial pneumonias, autoimmune- associated ILD, acuity pneumonitis, sarcoidosis and other kinds of ILD2.
According to exploration on GBD 2019 data, the global prevalence of ILD and pulmonary sarcoidosis has stoked to 118.6 between 1990- 2019 and could have contributed to 31.2 of all frequentness of habitual respiratory diseases in 2019.
Global Burden of Disease Study or GBD Study is the largest and most comprehensive scientific exercise ever accepted to measure the countries, and trends of global health. Over 12000 experimenters and interpreters from over 160 countries and homes have been involved in creating the most accurate, up- to- date, and similar estimates of burden across the world.
This is where the GBD Study gives an opportunity to calibrate the relative size of diseases, injuries, and risk factors for different ages, sexes, countries, regions, or time periods.